美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

20/20 BIOLABS INC

1.99

-0.0321-1.59%

盘后：1.990.00000.00%16:04 EDT

成交量：6.05万

成交额：12.10万

市值：2,059.09万

市盈率：-2.96

高：2.10

开：2.08

低：1.86

收：2.02

52周最高：50.00

52周最低：1.70

股本：1,034.72万

流通股本：539.85万

量比：0.40

换手率：1.12%

股息：- -

股息率：- -

每股收益(TTM):-0.6721

每股收益(LYR):-1.0679

净资产收益率：--

总资产收益率：--

市净率：336.00

市盈率(LYR):-1.86

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

20/20 BIOLABS INC

交易所：

NASDAQ

成立时间：

2000

员工人数：

19

公司地址：

15810 Gaither Road,Suite 235,Gaithersburg,Maryland,United States

官网：

http://2020biolabs.com

邮编：

20877

电话：

传真：

- -

简介：

20/20 Biolabs, Inc.于2000年8月7日在特拉华州注册成立。该公司开发和商业化人工智能驱动的、基于实验室的血液测试，专注于癌症和慢性疾病的早期检测和预防。该公司在OneTest品牌下提供两个主要的实验室测试家族：OneTest for Cancer，这是一种多癌种早期检测血液测试，以及OneTest for Longevity，预计将于2026年上半年推出。这两项测试均在该公司位于马里兰州盖瑟斯堡的CAP认证和CLIA许可实验室进行，该实验室还设有专为诊断初创企业设计的临床实验室创新加速器。

董事

名称

职位

John G. Compton

Chairman of the Board

Jonathan Cohen

Chief Executive Officer, President and Director

John W. Rollins

Director

Michael A. Ross

Director

Prasanth Reddy

Director

Richard M. Cohen

Director

Wei Lu

Director

股东

名称

职位

Jonathan Cohen

Chief Executive Officer, President and Director

Jiming Zhou

Chief Operating Officer

Alan B. Bergman

Chief Financial Officer

Michael Lebowitz

Chief Scientific Officer

Ron Baker

Chief Business Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/AIDX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AIDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AIDX\",,,,,undefined,":{"symbol":"AIDX","market":"US","secType":"STK","nameCN":"20/20 BIOLABS INC","latestPrice":1.99,"timestamp":1774296000000,"preClose":2.0221,"halted":0,"volume":60457,"hourTrading":{"tag":"盘后","latestPrice":1.99,"preClose":1.99,"latestTime":"16:04 EDT","volume":35,"amount":69.65,"timestamp":1774296270896,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.015874585826615904,"floatShares":5398500,"shares":10347200,"eps":-0.6721,"marketStatus":"盘后交易","change":-0.0321,"latestTime":"03-23 16:09:00 EDT","open":2.08,"high":2.1004,"low":1.86,"amount":121035.1518,"amplitude":0.118886,"askPrice":2.17,"askSize":1,"bidPrice":1.86,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.6721,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774310400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":2.0221,"preHourTrading":{"tag":"盘前","latestPrice":2.05,"preClose":1.98,"latestTime":"09:28 EDT","volume":5214,"amount":10611.697562399999,"timestamp":1774272489760,"change":0.07,"changeRate":0.035354,"amplitude":0.027071},"postHourTrading":{"tag":"盘后","latestPrice":1.99,"preClose":1.99,"latestTime":"16:04 EDT","volume":35,"amount":69.65,"timestamp":1774296270896,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.404271},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AIDX\",,,,,undefined,":{"symbol":"AIDX","floatShares":5398500,"roa":"--","roe":"--","lyrEps":-1.067939,"volumeRatio":0.404271,"shares":10347200,"dividePrice":0,"high":2.1004,"amplitude":0.118886,"preClose":2.0221,"low":1.86,"week52Low":1.6991,"pbRate":"336.00","psRate":"10.08","week52High":50,"institutionHeld":0,"latestPrice":1.99,"committee":0.996008,"eps":-0.6721,"divideRate":0,"volume":60457,"delay":0,"ttmEps":-0.6721,"open":2.08,"prevYearClose":50,"prevWeekClose":2.0221,"prevMonthClose":3.82,"prevQuarterClose":50,"fiveDayClose":2.5,"twentyDayClose":10.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AIDX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AIDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AIDX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AIDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AIDX","date":"2026-03-20","current":-2.960869,"percent":1,"low":-75.813841,"twenty":-17.858388,"median":-9.615801,"eighty":-7.966017,"high":-5.976101,"avg":-16.377643,"sd":16.164969,"marketCap":19452796},"quantilePoints":[{"date":"2026-02-20","current":-75.813841,"twenty":-64.065097,"median":-46.44198,"eighty":-28.818864,"marketCap":246781483},{"date":"2026-02-27","current":-12.969412,"twenty":-44.148132,"median":-25.366644,"eighty":-17.267187,"marketCap":42216706},{"date":"2026-03-06","current":-9.85421,"twenty":-31.342746,"median":-15.019766,"eighty":-10.648904,"marketCap":32076419},{"date":"2026-03-13","current":-7.883368,"twenty":-23.904406,"median":-10.776055,"eighty":-8.926007,"marketCap":25661135},{"date":"2026-03-20","current":-5.976101,"twenty":-17.858388,"median":-9.615801,"eighty":-7.966017,"marketCap":19452796}],"updateTime":1774296540205},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":7685164,"yearFounded":2000,"employeeNum":19,"address":"15810 Gaither Road,Suite 235,Gaithersburg,Maryland,United States","zipCode":"20877","officePhone":"(240) 453-6339"},"stockCompanyDetail":{"websiteUrl":"http://2020biolabs.com","stockEarnings":[{"period":"1week","weight":-0.2008},{"period":"1month","weight":-0.9596},{"period":"ytd","weight":-0.9596}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"20/20 Biolabs, Inc.于2000年8月7日在特拉华州注册成立。该公司开发和商业化人工智能驱动的、基于实验室的血液测试，专注于癌症和慢性疾病的早期检测和预防。该公司在OneTest品牌下提供两个主要的实验室测试家族：OneTest for Cancer，这是一种多癌种早期检测血液测试，以及OneTest for Longevity，预计将于2026年上半年推出。这两项测试均在该公司位于马里兰州盖瑟斯堡的CAP认证和CLIA许可实验室进行，该实验室还设有专为诊断初创企业设计的临床实验室创新加速器。","exchange":"NASDAQ","name":"20/20 BIOLABS INC","nameEN":"20/20 BIOLABS INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AIDX\",market:\"US\",,,undefined,":{"directors":[{"name":"John G. Compton","position":"Chairman of the Board"},{"name":"Jonathan Cohen","position":"Chief Executive Officer, President and Director"},{"name":"John W. Rollins","position":"Director"},{"name":"Michael A. Ross","position":"Director"},{"name":"Prasanth Reddy","position":"Director"},{"name":"Richard M. Cohen","position":"Director"},{"name":"Wei Lu","position":"Director"}],"executives":[{"name":"Jonathan Cohen","position":"Chief Executive Officer, President and Director"},{"name":"Jiming Zhou","position":"Chief Operating Officer"},{"name":"Alan B. Bergman","position":"Chief Financial Officer"},{"name":"Michael Lebowitz","position":"Chief Scientific Officer"},{"name":"Ron Baker","position":"Chief Business Officer"}]}}}